Europe Breast Lesion Localization Methods Market – Industry Trends and Forecast to 2029

Inhaltsverzeichnis anfordernInhaltsverzeichnis anfordern Mit Analyst sprechen Mit Analyst sprechen Jetzt kaufenJetzt kaufen Vor dem Kauf anfragen Vorher anfragen Kostenloser Beispielbericht Kostenloser Beispielbericht

Europe Breast Lesion Localization Methods Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Reports
  • Jan 2022
  • Europe
  • 350 Seiten
  • Anzahl der Tabellen: 220
  • Anzahl der Abbildungen: 60

Europe Breast Lesion Localization Methods Market

Marktgröße in Milliarden USD

CAGR :  % Diagram

Diagramm Prognosezeitraum
2023 –2029
Diagramm Marktgröße (Basisjahr)
MILLIONEN USD
Diagramm Marktgröße (Prognosejahr)
MILLIONEN USD
Diagramm CAGR
%
Diagramm Wichtige Marktteilnehmer
  • CP Medical
  • Cianna Medical
  • STERYLAB S.r.l.
  • SOMATEX Medical Technologies GmbH
  • Elucent Medical

Europe Breast Lesion Localization Methods Market, By Type (Wire Localization, Radioisotope Localization, Radioactive Seed Localization, Radio Occult Lesion Localization, Magnetic Tracers, Others), Biopsy Techniques (Fine Needle Aspiration Biopsy, Core Needle Biopsy, Surgical Biopsy, Incisional Biopsy, Excisional Biopsy, Vacuum-Assisted Breast Biopsy, Others), End-user (Diagnostic Centres, Hospitals, Oncology Clinics, Ambulatory Surgical Centres), Usage (Tumor Identification, Sentinel Lymph Node Lumpectomy), Country (Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia and Rest of Europe) Industry Trends and Forecast to 2029

Europe Breast Lesion Localization Methods Market

Market Analysis and Insights Europe Breast Lesion Localization Methods Market

Data Bridge Market Research analyses that the breast lesion localization methods market to growing at a CAGR of 13.30% in the forecast period of 2022-2029. Data Bridge Market Research analyses the market growth rate at the above-mentioned forecast period.

A breast lesion or injury is an abnormal change in breast tissue caused by disease or injury. A benign lesion is non-cancerous, whereas a malignant lesion is cancerous. Breast lumps are frequently reported by women of all ages. Breast lumps can also cause changes in the shape of the breast as well as pain. More than 90% of bumps cause benign cancer, but 10% of bumps can cause malignant cancer. Breast cancer can be diagnosed using a triple test that includes a physical examination, imaging, and a biopsy of the breasts.

The breast lesion localization methods market is being driven by the rising incidence of breast cancer. The number of breast cancer cases has increased significantly. This is primarily due to the increased use of oral contraceptives, changing lifestyles, and an increase in the number of women undergoing cosmetic surgeries such as breast enhancement. Furthermore, the introduction of technologically advanced products that are safe, accurate, and cost-effective is regarded as an important factor driving the breast lesion localization methods market.

Nevertheless, technological advancements, increased public awareness of breast cancer diagnosis, and untapped potential in emerging markets provide favourable growth opportunities.

However, uncertainty in regulatory approval procedure is limiting market growth. Furthermore, the approval process is lengthy and capital-intensive, making it difficult for small manufacturers and businesses with limited budgets to compete in this market. As a result, the North America breast lesion localization methods market's overall growth is hampered.

This breast lesion localization methods market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on breast lesion localization methods market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Breast Lesion Localization Methods Market Scope and Market Size

Breast lesion localization methods market is segmented on the basis of type, biopsy techniques, end user and usage. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • Based on type, the breast lesion localization methods market is segmented into wire localization, radioisotope localization, magnetic tracers and others.
  • Based on biopsy techniques, the breast lesion localization methods market is segmented into fine needle aspiration biopsy, core needle biopsy, surgical biopsy, vacuum-assisted breast biopsy and others.
  • Based on end user, the breast lesion localization methods market is segmented into diagnostic centres, hospitals, oncology clinics and ambulatory surgical centres. 
  • On the basis of usage, the breast lesion localization methods market is segmented into tumor identification and sentinel lymph node lumpectomy.

Breast Lesion Localization Methods Market Country Level Analysis

The breast lesion localization methods market is analysed and market size insights and trends are provided by country, type, biopsy techniques, end user and usage as referenced above.

The countries covered in the breast lesion localization methods market report are Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia and Rest of Europe.

The country section of the breast lesion localization methods market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The breast lesion localization methods market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for breast lesion localization methods market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the breast lesion localization methods market. The data is available for historic period 2010 to 2020.

Competitive Landscape and Breast Lesion Localization Methods Market Share Analysis

The breast lesion localization methods market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to breast lesion localization methods market.

Some of the major players operating in the breast lesion localization methods market are CP Medical, Inc., Cianna Medical, STERYLAB S.r.l., SOMATEX Medical Technologies GmbH, Elucent Medical, ARGON MEDICAL, Tsunami S.r.l., M.D.L. srl and Biomedical Srl, BD, Endomagnetics, Cook Medical, Cianna Medical, Leica Biosystems, Health Beacon, Intra-Medical Imaging LLC, Isoaid, LLC, Surgiceye GmbH, and Ranfac Corporation among others.


SKU-

Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud

  • Interaktives Datenanalyse-Dashboard
  • Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
  • Zugriff für Research-Analysten für Anpassungen und Abfragen
  • Konkurrenzanalyse mit interaktivem Dashboard
  • Aktuelle Nachrichten, Updates und Trendanalyse
  • Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Demo anfordern

Forschungsmethodik

Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.

Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.

Anpassung möglich

Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.

Häufig gestellte Fragen

Europe Breast Lesion Localization Methods Market to grow at a CAGR 13.30% by forecast 2029.
Major players operating in the breast lesion localization methods market are CP Medical, Inc., Cianna Medical, STERYLAB S.r.l., SOMATEX Medical Technologies GmbH, Elucent Medical, ARGON MEDICAL, Tsunami S.r.l., M.D.L. srl and Biomedical Srl, BD, Endomagnetics, Cook Medical, Cianna Medical, Leica Biosystems, Health Beacon, Intra-Medical Imaging LLC, Isoaid, LLC, Surgiceye GmbH, and Ranfac Corporation.
The countries covered in the breast lesion localization methods market report are Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, and the Rest of Europe.